Search company, investor...
Moexa Pharmaceuticals company logo

Moexa Pharmaceuticals

moexa.com

Founded Year

2014

About Moexa Pharmaceuticals

Moexa Pharmaceuticals is a multi-national drug research and development company engaging in proprietary Smad3 signaling technology. The company has developed anti-tumor therapeutics that address unmet medical needs in cancer immunotherapy, and in fibrotic disease, with solid patents in place protecting IP. The company is expanding its pipeline and advancing towards FDA IND approvals and has active interest from major pharma partners pending the conclusion of IND approval.

Headquarters Location

38 Trevose Cresent, 02 28

297722,

Singapore

+6588389524

Loading...

Loading...

Moexa Pharmaceuticals Patents

Moexa Pharmaceuticals has filed 1 patent.

The 3 most popular patent topics include:

  • clusters of differentiation
  • experimental cancer drugs
  • oncology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

8/6/2019

Oncology, Experimental cancer drugs, Clusters of differentiation, Transcription factors, Proteins

Application

Application Date

8/6/2019

Grant Date

Title

Related Topics

Oncology, Experimental cancer drugs, Clusters of differentiation, Transcription factors, Proteins

Status

Application

Moexa Pharmaceuticals Frequently Asked Questions (FAQ)

  • When was Moexa Pharmaceuticals founded?

    Moexa Pharmaceuticals was founded in 2014.

Loading...

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.